Aptamer-Dye Assays for Selective Methamphetamine Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current aptamer-based methods struggle to reproducibly achieve high affinity and specificity for low epitope small molecules in complex samples, often showing poor selectivity and cross-reactivity to structurally similar compounds, and require multi-step, instrument-intensive workflows unsuitable for point-of-care or field deployment.

Innovation Solution

Development of aptamers with specific nucleic acid sequences, such as SEQ ID NOS: 45, 46, 57, 64, and 65, that exhibit low cross-reactivity to structural analogs and enantiomers, combined with an aggregation-sensitive dye for optical or electrochemical signal detection, enabling simple and rapid assays in various sample types.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional SELEX workflows immobilize the target on a solid support to enable partitioning, then assay sensitivity is improved, but aptamer affinity and specificity for free solution phase analyte deteriorates

Engineering Contradiction:
Improveassay sensitivityVSAvoidaptamer affinity for free analyte
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent uses a soluble polymer carrier (PEG or dextran) as an intermediary to present the small molecule target in a soluble, non-immobilized state that mimics the free analyte environment. This allows aptamers to be selected against the target while maintaining their ability to bind free analyte in solution, resolving the contradiction between assay sensitivity and binding affinity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If aptamers are selected for high affinity binding, then detection sensitivity is improved, but selectivity against structurally similar compounds deteriorates

Engineering Contradiction:
Improvedetection sensitivityVSAvoidselectivity against analogs
Core Design Contradiction:
Measurement precisionVSManufacturing precision

Solution Approach 1:

The patent modifies selection parameters by using soluble polymer-conjugated targets instead of immobilized targets, changing the binding environment from surface-bound to solution-phase. This parameter change enables the selection of aptamers that achieve high affinity through optimal molecular interactions while maintaining selectivity by recognizing specific structural features of the target in a physiologically relevant environment.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If complex multi-step workflows are used to achieve high specificity, then detection accuracy is improved, but device complexity and cost increase

Engineering Contradiction:
Improvedetection accuracyVSAvoidworkflow complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts the essential function of target presentation from complex immobilization protocols and simplifies it to a single soluble polymer conjugation step. This eliminates the need for solid support immobilization, multiple washing steps, and specialized instrumentation, reducing workflow complexity while maintaining detection accuracy through the inherent specificity of aptamer-target binding in solution.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The aptamers demonstrate high specificity and affinity for phenethylamine-class compounds like (+)-methamphetamine, reducing cross-reactivity and enabling rapid, cost-effective detection in complex samples without the need for specialized equipment.

Implementation Method 1

The aptamers are complexed with an aggregation-sensitive dye and produce a detectable optical signal or electrochemical signal upon analyte binding

Methodology Applied
Scientific EffectAggregation-sensitive dye signal transduction: Absorption Spectroscopy

Data Source

PatentUS20260049321A1Methods and compositions of aptamers for detection of low complexity molecules
Publication Date: 2026.02.19 NORTH CAROLINA STATE UNIV
  • US20260049321A1 patent drawing
  • US20260049321A1 patent drawing
  • US20260049321A1 patent drawing

AI summary

Disclosed herein are methods and compositions for detecting (+)-methamphetamine using dye-complexed and redox-tag-labeled aptamers that generate a detectable signal upon target binding.